KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $230,000 | -74.6% | 61,177 | -58.5% | 0.01% | -78.6% |
| Q1 2017 | $907,000 | +398.4% | 147,400 | +328.5% | 0.04% | -28.8% |
| Q3 2016 | $182,000 | -61.4% | 34,400 | -51.7% | 0.06% | +156.5% |
| Q2 2016 | $471,000 | -88.1% | 71,254 | -82.0% | 0.02% | -82.6% |
| Q2 2015 | $3,951,000 | +77.6% | 395,913 | +151.7% | 0.13% | +59.0% |
| Q4 2014 | $2,225,000 | -49.7% | 157,314 | -39.4% | 0.08% | -64.5% |
| Q1 2014 | $4,420,000 | +288.4% | 259,439 | +195.0% | 0.23% | +290.0% |
| Q4 2013 | $1,138,000 | -39.5% | 87,951 | -52.8% | 0.06% | -41.7% |
| Q3 2013 | $1,880,000 | +72.6% | 186,349 | +27.7% | 0.10% | +186.1% |
| Q2 2013 | $1,089,000 | – | 145,898 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |